Shares of Johnson Matthey PLC (LON:JMAT - Get Free Report) reached a new 52-week low on Thursday . The company traded as low as GBX 1,289 ($16.41) and last traded at GBX 1,308 ($16.65), with a volume of 1724131 shares trading hands. The stock had previously closed at GBX 1,334 ($16.98).
Analyst Upgrades and Downgrades
Separately, Jefferies Financial Group reissued a "buy" rating and issued a GBX 1,800 ($22.91) price objective on shares of Johnson Matthey in a research note on Tuesday, December 17th.
Check Out Our Latest Analysis on JMAT
Johnson Matthey Price Performance
The company has a quick ratio of 0.76, a current ratio of 1.45 and a debt-to-equity ratio of 62.73. The stock's 50-day moving average price is GBX 1,412.69 and its 200-day moving average price is GBX 1,434.40. The company has a market capitalization of £1.95 billion, a price-to-earnings ratio of 19.78, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.95.
Insider Buying and Selling
In other Johnson Matthey news, insider Liam Condon acquired 30 shares of the business's stock in a transaction that occurred on Wednesday, January 22nd. The shares were acquired at an average cost of GBX 1,362 ($17.34) per share, for a total transaction of £408.60 ($520.11). Also, insider Stephen Oxley bought 27 shares of the stock in a transaction on Wednesday, February 19th. The shares were acquired at an average cost of GBX 1,451 ($18.47) per share, with a total value of £391.77 ($498.69). Insiders purchased 84 shares of company stock worth $119,052 in the last quarter. Insiders own 0.61% of the company's stock.
Johnson Matthey Company Profile
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.
Featured Stories
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
